NASDAQ · CHRN
ChronoScale Holdings Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for CHRN has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Nov 2026 | $-0.13 | $-0.07 | $-0.19 | 2 |
| Feb 2027 | $-0.13 | $-0.10 | $-0.15 | 2 |
| May 2027 | $-0.09 | $-0.08 | $-0.11 | 2 |
| Aug 2027 | $0.02 | $0.09 | $-0.05 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · The Motley Fool · RTTNews- Zacks · Feb 26, 8:15 AM ESTIntegra LifeSciences (IART) Beats Q4 Earnings and Revenue EstimatesIntegra (IART) delivered earnings and revenue surprises of +4.73% and +0.13%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Feb 17, 9:40 AM ESTIs Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?Here is how Compass Therapeutics, Inc. (CMPX) and Ekso Bionics (EKSO) have performed compared to their sector so far this year.
- Zacks · Feb 2, 8:37 AM ESTBeat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in FocusFIVE, NVO and EKSO led gains as Zacks strategies beat the S&P 500, highlighting upgrades, focus lists and model portfolios.
- Fintel · Jan 13, 10:11 PM ESTEkso Bionics Holdings (EKSO) Price Target Increased by 22.58% to 9.69The average one-year price target for Ekso Bionics Holdings (NasdaqCM:EKSO) has been revised to $9.69 / share. This is an increase of 22.58% from the prior estimate of $7.90 dated December 18, 2025. The price target is an average of many targets provided by an
- The Motley Fool · Jan 11, 3:50 PM ESTApplied Digital Shares Surge on Bright Outlook. Is It Too Late to Buy the Stock?Applied Digital is seeing major revenue growth as it undergoes a business transformation.
- RTTNews · Dec 30, 11:30 AM ESTEkso Bionics Stock Soars 103% After Applied Digital Proposes Cloud Spin-Out(RTTNews) – Ekso Bionics Holdings, Inc. (EKSO) shares jumped 102.93%, closing at $11.08, up $5.62, after Applied Digital announced plans to spin out its cloud business, a move investors interpreted as potentially unlocking value for affiliates, including Ekso.
- RTTNews · Dec 30, 1:58 AM ESTApplied Digital To Merge Cloud Unit With EKSO, Creating AI Compute Platform(RTTNews) – Ekso Bionics Holdings Inc. (EKSO) jumped sharply in overnight trading after Applied Digital (APLD) announced plans to spin out its cloud computing business and merge it with EKSO to form ChronoScale, a purpose-built accelerated compute platform designed for next-gener
- Zacks · Nov 21, 12:00 PM ESTEkso Bionics (EKSO) Upgraded to Buy: Here's WhyEkso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- RTTNews · Nov 19, 11:43 PM ESTEarnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours(RTTNews) – Several stocks posted notable moves in Wednesday's after-hours session, extending momentum from the regular trading day or reversing earlier trends. Earnings announcements and recent financing updates shaped activity across healthcare, biotech, and technology names, w
- Fintel · Nov 18, 7:03 PM ESTHC Wainwright & Co. Maintains Ekso Bionics Holdings (EKSO) Buy RecommendationFintel reports that on November 18, 2025, HC Wainwright & Co. maintained coverage of Ekso Bionics Holdings (NasdaqCM:EKSO) with a Buy recommendation. Analyst Price Forecast Suggests 752.04% Upside
- Zacks · Oct 28, 5:15 PM EDTEkso Bionics (EKSO) Reports Q3 Loss, Beats Revenue EstimatesEkso Bionics (EKSO) delivered earnings and revenue surprises of +45.45% and +8.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Sep 26, 12:00 PM EDTEkso Bionics (EKSO) Upgraded to Buy: Here's What You Should KnowEkso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for ChronoScale Holdings Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.